Compounds / MOTS-c

MOTS-c

Mitochondrial ORF of the 12S rRNA type-c

MOTS-c has 5 registered human trials on record. It is marketed for 3 different uses.

In short

  • 5 registered human trials exist for MOTS-c.
  • No registered trial lists metabolic health, endurance & performance or longevity as a studied condition.
  • MOTS-c is not FDA-approved for any use.
  • What has actually been studied: chronic kidney disease, bilateral vestibular hypofunction.
  • 4 studies are open to new participants, so this may change.
  • Last checked against ClinicalTrials.gov on 2026-07-27.
5
Registered human trials
4
Recruiting or running
No
FDA approved
Pre
P1
P2
P3
Furthest stage reached

What it's sold for

  • Metabolic health
  • Endurance & performance
  • Longevity

What has actually been tested

  • Aminoglycoside Toxicity
  • Bilateral Vestibular Deficiency
  • Bilateral Vestibular Hypofunction
  • Bilateral Vestibulopathy
  • Breast Cancer
  • Chronic Kidney Disease
  • Gentamicin Ototoxicity
  • Insulin Resistance

Is it studied for what it's sold for?

Each claim below is matched against the condition and title fields of every registered trial. Not listed means no trial names it as a studied condition — not that it has been disproven, and not that no trial touches it indirectly.

Not listed Metabolic health
Not listed Endurance & performance
Not listed Longevity

Every trial on record

Every registered human study we can find for MOTS-c. Click any ID to read the original record — we would rather you checked us than trusted us.

Trial IDTitleConditionPhaseStatusEnrolled
NCT07438002 Analysis of Effects of High-intensity Physical Exercise in Subjects With Dialyzed Chronic Kidney Disease and in Conservative Treatment Chronic Kidney Disease Not phased Recruiting now 50
NCT06500975 Long Term Outcomes After Vestibular Implantation Bilateral Vestibular Hypofunction, Bilateral Vestibular Deficiency Not phased Recruiting now 32
NCT07505745 MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity Prediabetes, Insulin Resistance Phase 2 Recruiting now 120
NCT07678073 Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation Kidney Disease, End-Stage, Kidney Transplant Not phased Recruiting now 68
NCT04013568 Exercise Post-Diagnosis of Breast Cancer Breast Cancer Not phased Completed 62
Read this
A trial count is not a verdict
These numbers describe how much has been formally studied in humans, not whether something works or is safe for you. A compound can be tested for one condition and sold for another — which is usually the story. This page is automated aggregation from public registries; no physician has reviewed it. Take anything here to a clinician.

Common questions about MOTS-c

How many human trials does MOTS-c have?

5. That is the number of registered interventional human studies we can find, each listed on this page with a link to its original record.

Is MOTS-c FDA approved?

No. MOTS-c is not approved by the FDA for any indication. Compounded or "research use only" preparations are not FDA-approved and receive no premarket review for safety, effectiveness, or manufacturing quality.

What is MOTS-c actually being tested for?

Registered studies cover: chronic kidney disease, bilateral vestibular hypofunction, bilateral vestibular deficiency. Compare that to what it is marketed for — the two lists are often different, which is the whole point of this page.

Where does this data come from?

ClinicalTrials.gov, the US public registry of clinical studies. We count interventional human studies only — observational studies are not evidence of effect. Every trial on this page links to its original record so you can check us rather than trust us.

Get told when this changes

One email a week: what moved in the research, and which claims the record doesn't support. Free, and you can leave in one click.